ID   BIHi004-A
AC   CVCL_IT55
SY   NHDF Epi5 Cl5 iPSC; EpiCl5 iPSC
DR   BioSamples; SAMEA103992834
DR   hPSCreg; BIHi004-A
DR   SKIP; SKIP002682
DR   Wikidata; Q54796561
RX   PubMed=27138223;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU81 ! BIHi004-B
OI   CVCL_WU82 ! BIHi004-C
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 9
//
RX   PubMed=27138223; DOI=10.1371/journal.pone.0154770;
RA   Hossini A.M., Quast A.S., Plotz M., Grauel K., Exner T., Kuchler J.,
RA   Stachelscheid H., Eberle J., Rabien A., Makrantonaki E.,
RA   Zouboulis C.C.;
RT   "PI3K/AKT signaling pathway is essential for survival of induced
RT   pluripotent stem cells.";
RL   PLoS ONE 11:E0154770-E0154770(2016).
//